ADVANCED PATHOPHYSIOLOGY & PHARMACOLOGY
NUR-641E Final Exam Prep A+
2026/2027
Advanced Pathophysiology and Pharmacology for Nurse Educators — Official-Style Comprehensive
Assessment
A+ QUESTIONS 5 SECTIONS 100% RATIONALES
VERIFIED COVERED INCLUDED
CATEGORIES
■ 1. Pharmacokinetics & Pharmacodynamics
■ 2. Adverse Drug Reactions & Medication Safety
■ 3. Cardiovascular Pathophysiology & Pharmacology
■ 4. Endocrine, Renal & Selected System Pharmacology
■ 5. Cellular Injury, Inflammation, Immunity & Infection
Passing Score: 80% | Marks: 1 per question | Bloom’s Level: Application / Analysis
STUVIAACTUALEXAM
, SECTION 1: Pharmacokinetics & Pharmacodynamics
Q1. A 68-year-old patient with heart failure is started on digoxin. The nurse educator reviews that steady-state
plasma concentration for most drugs is typically reached after how many half-lives?
A. 4–5 half-lives
B. 1–2 half-lives
C. 2–3 half-lives
D. 7–10 half-lives
Correct Answer: A
Rationale: Steady state is generally achieved after approximately 4–5 half-lives when the rate of drug administration equals
the rate of elimination. This principle guides dosing interval selection and monitoring of therapeutic levels.
Q2. An educator explains intravenous administration to graduate students. Which pharmacokinetic advantage is
unique to the intravenous route compared with oral or intramuscular routes?
A. It undergoes extensive first-pass hepatic metabolism
B. It provides 100% bioavailability by placing the entire dose into the systemic circulation
C. Absorption is highly variable depending on local tissue perfusion
D. Peak plasma levels are delayed relative to oral dosing
Correct Answer: B
Rationale: Intravenous administration bypasses absorption barriers and first-pass metabolism, delivering the entire dose
directly into the bloodstream and yielding essentially complete bioavailability.
Q3. A patient taking a CYP3A4 substrate is prescribed a strong CYP3A4 inducer. The most likely clinical
consequence is:
A. Increased plasma concentration and toxicity of the substrate
B. No change because inducers only affect Phase II conjugation
C. Decreased plasma concentration and potential loss of therapeutic effect of the substrate
D. Immediate irreversible inhibition of substrate metabolism
Correct Answer: C
Rationale: CYP3A4 inducers accelerate metabolism of substrate drugs, lowering their plasma levels and potentially
reducing efficacy. Grapefruit juice and certain azoles are classic inhibitors, not inducers.
Q4. Zero-order (nonlinear) kinetics are characterized by which statement?
A. A constant fraction of drug is eliminated per unit time
B. Elimination half-life remains constant regardless of dose
C. Clearance increases proportionally with plasma concentration
D. A constant amount of drug is metabolized per unit time
Correct Answer: D
Rationale: In zero-order kinetics the elimination system is saturated, so a fixed amount of drug is removed per unit time.
Ethanol and high-dose phenytoin classically exhibit this pattern.
NUR-641E Final Exam Prep 2026/2027 | Page 2
NUR-641E Final Exam Prep A+
2026/2027
Advanced Pathophysiology and Pharmacology for Nurse Educators — Official-Style Comprehensive
Assessment
A+ QUESTIONS 5 SECTIONS 100% RATIONALES
VERIFIED COVERED INCLUDED
CATEGORIES
■ 1. Pharmacokinetics & Pharmacodynamics
■ 2. Adverse Drug Reactions & Medication Safety
■ 3. Cardiovascular Pathophysiology & Pharmacology
■ 4. Endocrine, Renal & Selected System Pharmacology
■ 5. Cellular Injury, Inflammation, Immunity & Infection
Passing Score: 80% | Marks: 1 per question | Bloom’s Level: Application / Analysis
STUVIAACTUALEXAM
, SECTION 1: Pharmacokinetics & Pharmacodynamics
Q1. A 68-year-old patient with heart failure is started on digoxin. The nurse educator reviews that steady-state
plasma concentration for most drugs is typically reached after how many half-lives?
A. 4–5 half-lives
B. 1–2 half-lives
C. 2–3 half-lives
D. 7–10 half-lives
Correct Answer: A
Rationale: Steady state is generally achieved after approximately 4–5 half-lives when the rate of drug administration equals
the rate of elimination. This principle guides dosing interval selection and monitoring of therapeutic levels.
Q2. An educator explains intravenous administration to graduate students. Which pharmacokinetic advantage is
unique to the intravenous route compared with oral or intramuscular routes?
A. It undergoes extensive first-pass hepatic metabolism
B. It provides 100% bioavailability by placing the entire dose into the systemic circulation
C. Absorption is highly variable depending on local tissue perfusion
D. Peak plasma levels are delayed relative to oral dosing
Correct Answer: B
Rationale: Intravenous administration bypasses absorption barriers and first-pass metabolism, delivering the entire dose
directly into the bloodstream and yielding essentially complete bioavailability.
Q3. A patient taking a CYP3A4 substrate is prescribed a strong CYP3A4 inducer. The most likely clinical
consequence is:
A. Increased plasma concentration and toxicity of the substrate
B. No change because inducers only affect Phase II conjugation
C. Decreased plasma concentration and potential loss of therapeutic effect of the substrate
D. Immediate irreversible inhibition of substrate metabolism
Correct Answer: C
Rationale: CYP3A4 inducers accelerate metabolism of substrate drugs, lowering their plasma levels and potentially
reducing efficacy. Grapefruit juice and certain azoles are classic inhibitors, not inducers.
Q4. Zero-order (nonlinear) kinetics are characterized by which statement?
A. A constant fraction of drug is eliminated per unit time
B. Elimination half-life remains constant regardless of dose
C. Clearance increases proportionally with plasma concentration
D. A constant amount of drug is metabolized per unit time
Correct Answer: D
Rationale: In zero-order kinetics the elimination system is saturated, so a fixed amount of drug is removed per unit time.
Ethanol and high-dose phenytoin classically exhibit this pattern.
NUR-641E Final Exam Prep 2026/2027 | Page 2
